Oncotelic Therapeutics, Inc. Interest Expense Nonoperating
Oncotelic Therapeutics, Inc. (OTLC) reported Interest Expense Nonoperating of $318.29 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-13
- Oncotelic Therapeutics, Inc. interest expense nonoperating for the quarter ending 2026-06-30 was $318.29K, a 53.19% increase year-over-year.
- Oncotelic Therapeutics, Inc. interest expense nonoperating for the quarter ending 2025-06-30 was $207.78K.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month |
|---|---|---|
| 2026-06-30 | $318.29K 10-Q · filed 2026-08-13 | $614.10K 10-Q · filed 2026-08-13 |
| 2025-06-30 | $207.78K 10-Q · filed 2026-08-13 | $411.58K 10-Q · filed 2026-08-13 |